Welltower income statement
In fiscal 2025, Welltower reported revenue of $10.84bn, up 35.6% on the year before and net income of $937m, or $1.39 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.5 | 0.6 | 1.3 | 1.8 | 2.9 | 3.3 | 3.9 | 4.3 | 4.3 | 4.7 | 5.1 | 4.6 | 4.7 | 5.9 | 6.6 | 8.0 | 10.8 | 13.8 |
| Cost of revenue | — | — | — | — | — | — | — | — | 2.1 | 2.4 | 2.7 | 2.6 | 2.8 | 3.6 | 3.9 | 4.8 | 6.5 | 8.4 |
| Gross profit | — | — | — | — | — | — | — | — | 2.2 | 2.3 | 2.4 | 2.0 | 2.0 | 2.3 | 2.7 | 3.2 | 4.3 | 5.4 |
| Selling, general and administrative | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 1.7 | 1.8 |
| Interest expense | 0.1 | 0.1 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.6 | — | — | — |
| Provision for credit losses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 |
| Income before tax | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.4 | 0.6 | 0.7 | 0.3 | 0.4 | 0.5 | −0.0 | 0.2 | 0.2 | 0.4 | 0.5 | — | — |
| Income tax | 0.0 | 0.0 | −0.0 | 0.0 | 0.0 | −0.0 | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0 | −0.0 |
| Net income | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.4 | 0.8 | 1.0 | 0.5 | 0.8 | 1.2 | 1.0 | 0.3 | 0.1 | 0.3 | 1.0 | 0.9 | 1.7 |
| Diluted EPS | $1.49 | $0.83 | $0.90 | $0.98 | $0.28 | $1.45 | $2.34 | $2.81 | $1.26 | $2.02 | $3.05 | $2.33 | $0.78 | $0.30 | $0.66 | $1.57 | $1.39 | $2.28 |
| Diluted shares (average) | 115m | 128m | 174m | 226m | 279m | 308m | 349m | 360m | 369m | 375m | 404m | 417m | 427m | 465m | 519m | 609m | 680m | 732m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,251 | 2,423 | 2,548 | 2,686 | 3,181 | 3,352 | 3,545 | 3,716 |
| Cost of revenue | 1,409 | 1,462 | 1,515 | 1,577 | 1,934 | 2,055 | 2,150 | 2,246 |
| Gross profit | 842 | 961 | 1,034 | 1,109 | 1,247 | 1,297 | 1,394 | 1,470 |
| Selling, general and administrative | 49 | 64 | 64 | 63 | 1,557 | 67 | 67 | 67 |
| Provision for credit losses | −0 | −2 | −1 | 1 | −7 | 2 | 2 | 0 |
| Income before tax | 109 | 199 | 298 | 293 | — | 345 | 320 | 338 |
| Income tax | 0 | −6 | 1 | 2 | −5 | 12 | −62 | 7 |
| Net income | 120 | 258 | 302 | 281 | 96 | 729 | 445 | 397 |
| Diluted EPS | $0.18 | $0.40 | $0.45 | $0.41 | $0.13 | $1.02 | $0.61 | $0.54 |
Compare with peers
- Ventas income statement
- Healthpeak Properties income statement
- American Healthcare Reit, Inc. income statement
- Diversified Healthcare Trust income statement
- Omega Healthcare Investors Inc income statement
Head to head: VTR vs WELLDOC vs WELLAHR vs WELL
More: Health Care REITs stocks compared, Real Estate sector, rankings of US companies